Covered recipient · General Payments record
DAVID LUSTIG
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$335.87
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.32 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $51.47 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.37 | 2 |
| GlaxoSmithKline, LLC. | $30.66 | 2 |
| Novo Nordisk AS | $18.85 | 1 |
| ABBVIE INC. | $16.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.97 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104913529 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.74 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117953199 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.63 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117953197 | CMS |
| GlaxoSmithKline, LLC. | $13.16 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115982156 | CMS |
| GlaxoSmithKline, LLC. | $17.50 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116654717 | CMS |
| Lilly USA, LLC | $15.43 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140679 | CMS |
| Lilly USA, LLC | $17.98 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136147935 | CMS |
| Lilly USA, LLC | $18.06 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136118997 | CMS |
| Novo Nordisk Inc | $18.85 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096906863 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.